51 related articles for article (PubMed ID: 9303513)
21. Chronic hepatitis C: treatment of pegylated interferon/ribavirin nonresponders.
Shiffman ML
Curr Gastroenterol Rep; 2006 Feb; 8(1):46-52. PubMed ID: 16510034
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hepatitis C. The 2002 French consensus.
Dhumeaux D; Marcellin P; Lerebours E
Gut; 2003 Dec; 52(12):1784-7. PubMed ID: 14633963
[No Abstract] [Full Text] [Related]
23. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.
Peterson JR; Hsu FC; Simkin PA; Wener MH
Ann Rheum Dis; 2003 Nov; 62(11):1078-82. PubMed ID: 14583571
[TBL] [Abstract][Full Text] [Related]
24. Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin.
Arif A; Levine RA; Sanderson SO; Bank L; Velu RP; Shah A; Mahl TC; Gregory DH
Dig Dis Sci; 2003 Jul; 48(7):1425-30. PubMed ID: 12870807
[TBL] [Abstract][Full Text] [Related]
25. Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis.
Stein DF; Myaing M
Dig Dis Sci; 2002 Dec; 47(12):2686-90. PubMed ID: 12498286
[TBL] [Abstract][Full Text] [Related]
26. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Burroughs AK; Groszmann R; Bosch J; Grace N; Garcia-Tsao G; Patch D; Garcia-Pagan JC; Dagher L
Gut; 2002 Mar; 50(3):425-7. PubMed ID: 11839726
[TBL] [Abstract][Full Text] [Related]
27. Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?
Shiffman ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):30-7. PubMed ID: 11177692
[TBL] [Abstract][Full Text] [Related]
28. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.
Farges O; Malassagne B; Flejou JF; Balzan S; Sauvanet A; Belghiti J
Ann Surg; 1999 Feb; 229(2):210-5. PubMed ID: 10024102
[TBL] [Abstract][Full Text] [Related]
29. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
30. Treatment of HCV liver disease by recombinant interferon alpha.
Bailly F; Si N; Si A; Trepo C
Nephrol Dial Transplant; 1996; 11 Suppl 4():56-7. PubMed ID: 8918757
[TBL] [Abstract][Full Text] [Related]
31. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
Shiffman ML; Hofmann CM; Thompson EB; Ferreira-Gonzalez A; Contos MJ; Koshy A; Luketic VA; Sanyal AJ; Mills AS; Garrett CT
Hepatology; 1997 Sep; 26(3):780-5. PubMed ID: 9303513
[TBL] [Abstract][Full Text] [Related]
32. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.
Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ; Contos MJ; Mills AS
Hepatology; 1996 Jul; 24(1):21-6. PubMed ID: 8707264
[TBL] [Abstract][Full Text] [Related]
33. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
[TBL] [Abstract][Full Text] [Related]
34. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
Reichard O; Glaumann H; Norkrans G; Wejstål R; Fryden A; Schvarcz R; Weiland O
Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108
[TBL] [Abstract][Full Text] [Related]
35. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients.
Manesis EK; Papaioannou C; Gioustozi A; Kafiri G; Koskinas J; Hadziyannis SJ
Hepatology; 1997 Sep; 26(3):734-9. PubMed ID: 9303505
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
